Tuesday, lub FDA tso cai nrawm nrawm rau ImmunoGen Inc (Nasdaq: IMGN) Elahere (mirvetuximab soravtansine-gynx) rau folate receptor alpha (FRα)-zoo, platinum-resistant epithelial zes qe menyuam, fallopian tube, lossis thawj kab mob qog noj ntshav.
HC Wainwright hais tias daim ntawv pov thawj pom zoo tsis xav tau kev kho mob ua ntej nrog bevacizumab, uas raws li kev tswj hwm, tuaj yeem yuav luag ob npaug ntawm cov neeg mob tsim nyog.
Tus kws tshuaj ntsuam tau nce tus nqi phiaj los ntawm $ 12 txog $ 20, nrog kev yuav khoom ntsuas.
Elahere daim ntawv lo dav dua li qhov kev cia siab yuav tshwm sim los ntawm FDA qhov kev nkag mus rau qhov ua ntej lub hom phiaj teb tus nqi (ORR) thiab lub sijhawm teb (DOR) cov ntaub ntawv los ntawm ob sab caj npab ntawm MIRASOL txoj kev tshawb fawb.
Elahere daim ntawv lo suav nrog lub thawv ntawv ceeb toom rau cov tshuaj ocular toxicity, tab sis HC Wainwright ntseeg tias nws yuav muaj feem cuam tshuam rau Elahere txoj kev saws me nyuam.
Txhua 21-hnub kev kho mob yuav raug nqi $ 18,000- $ 25,000, nrog tus nqi txhua xyoo ntawm $ 182,400 rau ib tus neeg mob.
BMO Capital Markets hais tias ImmunoGen shares tau nyob rau hauv siab (-13% vs. -0.26% XBI) tom qab Elaher pom zoo lub rooj sib tham hu, uas yog ib qho surprise.
Tus kws tshuaj ntsuam BMO tau tsa tus nqi lub hom phiaj los ntawm $ 17 txog $ 19 ntawm kev nce ntxiv ntawm MIRASOL cov ntaub ntawv thaum ntxov 2023.
Tus kws tshuaj ntsuam xav tias mirvetuximab tsuas tuaj yeem ua tiav ~ $ 300 lab kev muag khoom siab tshaj plaws, ua rau muaj txiaj ntsig zoo rau kev mob qog noj ntshav ntawm zes qe menyuam.
Nqe Nqis: IMGN shares tau nce 5.09% ntawm $ 5.27 ntawm daim tshev kawg hnub Wednesday.
Qhov tseeb Ratings rau IMGN
Hnub | Tshaj tawm | Action | Los ntawm | Yuav |
|---|---|---|---|---|
Feb 2022  | SWB Leerink | Txij nkawm | Kev Ua Lag Luam | |
Feb 2022 | BMO Peev | Pib Kev Npam Ntawm | Txoj Kev Ua Txhaum | |
Dec 2021 | Jefferies | hloov khoom dua tshiab | tuav | yuav |
Saib Ntau Cov Kev Ntsuas Ntsuas rau IMGN
Saib Qhov Ntsuam Kev Ntsuam Xyuas Cov Ntaus Tawm Tshiab
Saib ntxiv ntawm Benzinga
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/fda-approval-ovarian-cancer-drug-192106962.html